Munyu weATP disodium CAS 987-65-5

CAS:987-65-5

Kuchena:99%

Fomura reMamorekuru:C10H17N5NaO13P3

Kurema kweMorekuru:531.18

EINECS:213-579-1

Nguva Yekuchengetera:makore maviri

Mazwi akafanana:ADENOSINETRIPHOSPHATEDISODIUM; ADENOSINETRIPHOSPHATE,DISODIUMMUNYU; ADENYLPYROPHOSPHORICACIDDISODIUMMUNYU; ADENOSI-5′-TRIPHOSPHATEHYDRATEDISODIUMMUNYU; ADENOSI-5′-TRIPHOSPHATENA2-MUNYU; ADENOSI-5′-TRIPHOSPHATENA2-MUNYU; ADENOSI-5′-TRIPHOSPHORICACIDDISODIUMMUNYU; ADENOSI-5′-TRIPHOSPHORICACIDDISODIUMMUNYU; ADENOSI-5′-TRIPHOSPHORICACIDDISODIUMMUNYU

Siya Mharidzo Yako

Ruzivo rweChigadzirwa

Dhawunirodha

Matagi eChigadzirwa

Chii chinonzi ATP disodium salt CAS 987-65-5?

Munyu weATP disodium imusanganiswa weadenosine, nucleoside triphosphate inoshanda zvakawanda inoshandiswa se coenzyme yekufambisa simba mukati memasero. Inotakura simba remakemikari mukati memasero kuti masero agayiwe. Munyu weATP disodium unoshandiswa kugadzira ribose-modified deoxyadenosine diphosphate analogs seP2Y1 receptor ligands.

Tsanangudzo

Chitarisiko	Upfu huchena kana husina kuchena - upfu huchena kana hupfu hwekristaro, husingaonekwe zvakanaka.
Saizi yezvimedu	> 95% inopfuura nepakati pe80 mesh.
pH	2.5～3.5
Kunyunguduka	Inonyungudika mumvura; hainyungudike mu ethanol ne ether.
Oder	Oderless
Mvura iri mukati	6.0%~12.0%
Chloride	≤0.05%
Munyu wesimbi	≤0.001%
Simbi dzinorema	≤0.001%
Tungamira	≤2.0ppm
Arsenic	≤1.0ppm

Kushandiswa

1. Mashandisirwo eongororo yezvemaindasitiri nesainzi
(1) Zvinhu zvekushongedza: kana zvawedzerwa kune zvigadzirwa zvekuchengetedza ganda zvinodzivirira kukwegura, zvinogona kuvandudza kutwasuka kweganda uye kupenya kwaro nekushandisa simba remasero.
(2) Zvekuwedzera zvekudya: zvinoshandiswa sekuwedzera hutano muzvinwiwa zvemitambo nezvikafu zvinoshanda kuti zvidzore simba nekukurumidza.
2. Nzvimbo dzekurapa dzekiriniki
(1) Zvirwere zvemwoyo: zvinoshandiswa pakurapa kutadza kwemoyo, myocarditis, myocardial infarction uye cerebral arteriosclerosis, nezvimwewo, nekuvandudza metabolism yesimba remwoyo uye kuwedzera tsinga dzemwoyo (kuwedzera kuyerera kweropa neinenge 30%), kuderedza zviratidzo zvemyocardial ischemia. Semuenzaniso, kune varwere vane acute myocardial infarction, ATP disodium inogona kupfupisa nguva yekudonha kweST segment uye kuderedza kukosha kwe peak ye myocardial enzyme spectrum.
(2) Zvirwere zvetsinga: kurapwa kwekuwedzera kwemigumisiro yekubuda ropa muuropi, kukuvara kweuropi uye kupera kwetsandanyama, nekupinda muropa-uropi (kupindira kweropa kunosvika 65%), kukurudzira kugadziriswa kwemasero etsinga uye kuvandudzwa kwemaitiro etsinga, uye kuvandudza kumhanya kwekufambiswa kwetsinga.
(3) Zvirwere zveMetabolic: Mukurapa hepatitis ne cirrhosis, ATP disodium inogona kuwedzera mashandiro e hepatocytes mu mitochondrial, kukurumidzisa kugadziriswa kwe hepatocytes, uye kuderedza mazinga e ALT ne AST; inewo mhedzisiro yekuvandudza pamatambudziko echirwere cheshuga (akadai se peripheral neuropathy).
3. Nzvimbo dziri kutanga kushandiswa
(1) Sisitimu yekuendesa mishonga yakanangana: ATP disodium inogona kushandiswa semuchina wekutakura, pamwe chete ne liposomes kana nanoparticles, kuti isvike pakuendeswa kwemishonga yakanangana ne receptor-mediated endocytosis. Semuenzaniso, mukurapa bundu, ATP-modified nanomedicines inogona kuvandudza kushanda kwemishonga ye chemotherapy pamasero ekenza.
(2) Kukura kwemasero uye mishonga yekurapa: Sechinhu chakakosha chekukura kwemasero, ATP disodium inogona kukurudzira kukura uye kuratidzwa kwemapuroteni emasero eCHO, masero eHEK293, nezvimwewo, uye inoshandiswa zvakanyanya mukugadzirwa kwemasoja ekudzivirira muviri emonoclonal.